708 related articles for article (PubMed ID: 18593587)
21. Hepatocellular carcinoma in long-term sustained virological responders following antiviral combination therapy for chronic hepatitis C.
Scherzer TM; Reddy KR; Wrba F; Hofer H; Staufer K; Steindl-Munda P; Gangl A; Ferenci P
J Viral Hepat; 2008 Sep; 15(9):659-65. PubMed ID: 18637075
[TBL] [Abstract][Full Text] [Related]
22. Interferon therapy does not prevent hepatocellular carcinoma in HCV compensated cirrhosis.
Testino G; Ansaldi F; Andorno E; Ravetti GL; Ferro C; De Iaco F; Icardi G; Valente U
Hepatogastroenterology; 2002; 49(48):1636-8. PubMed ID: 12397752
[TBL] [Abstract][Full Text] [Related]
23. The spectrum of chronic hepatitis C virus infection in the Virginia Correctional System: development of a strategy for the evaluation and treatment of inmates with HCV.
Sterling RK; Brown RS; Hofmann CM; Luketic VA; Stravitz RT; Sanyal AJ; Contos MJ; Mills AS; Smith V; Shiffman ML
Am J Gastroenterol; 2005 Feb; 100(2):313-21. PubMed ID: 15667488
[TBL] [Abstract][Full Text] [Related]
24. Detection of hepatitis C virus (HCV) RNA in the liver of healthy, anti-HCV antibody-positive, serum HCV RNA-negative patients with normal alanine aminotransferase levels.
Carreño V; Pardo M; López-Alcorocho JM; Rodríguez-Iñigo E; Bartolomé J; Castillo I
J Infect Dis; 2006 Jul; 194(1):53-60. PubMed ID: 16741882
[TBL] [Abstract][Full Text] [Related]
25. Long-term follow-up study of sustained biochemical responders with interferon therapy.
Shindo M; Hamada K; Oda Y; Okuno T
Hepatology; 2001 May; 33(5):1299-302. PubMed ID: 11343259
[TBL] [Abstract][Full Text] [Related]
26. Presence of hepatitis C virus (HCV)-RNA in peripheral blood mononuclear cells in HCV serum negative patients during interferon and ribavirin therapy.
Januszkiewicz-Lewandowska D; Wysocki J; Pernak M; Nowicka K; Zawada M; Rembowska J; Lewandowski K; Mańkowski P; Nowak J
Jpn J Infect Dis; 2007 Feb; 60(1):29-32. PubMed ID: 17314422
[TBL] [Abstract][Full Text] [Related]
27. A sustained viral response is associated with reduced liver-related morbidity and mortality in patients with hepatitis C virus.
Singal AG; Volk ML; Jensen D; Di Bisceglie AM; Schoenfeld PS
Clin Gastroenterol Hepatol; 2010 Mar; 8(3):280-8, 288.e1. PubMed ID: 19948249
[TBL] [Abstract][Full Text] [Related]
28. Development of hepatocellular carcinoma in patients with chronic hepatitis C who had a sustained virological response to interferon therapy: a multicenter, retrospective cohort study of 1124 patients.
Kobayashi S; Takeda T; Enomoto M; Tamori A; Kawada N; Habu D; Sakaguchi H; Kuroda T; Kioka K; Kim SR; Kanno T; Ueda T; Hirano M; Fujimoto S; Jomura H; Nishiguchi S; Seki S
Liver Int; 2007 Mar; 27(2):186-91. PubMed ID: 17311612
[TBL] [Abstract][Full Text] [Related]
29. Hepatitis C virus replicates in the liver of patients who have a sustained response to antiviral treatment.
Castillo I; Rodríguez-Iñigo E; López-Alcorocho JM; Pardo M; Bartolomé J; Carreño V
Clin Infect Dis; 2006 Nov; 43(10):1277-83. PubMed ID: 17051492
[TBL] [Abstract][Full Text] [Related]
30. Chronic hepatitis C in patients with persistently normal alanine transaminase levels.
Shiffman ML; Diago M; Tran A; Pockros P; Reindollar R; Prati D; Rodríguez-Torres M; Lardelli P; Blotner S; Zeuzem S
Clin Gastroenterol Hepatol; 2006 May; 4(5):645-52. PubMed ID: 16630770
[TBL] [Abstract][Full Text] [Related]
31. Detection of residual hepatitis C virus RNA by transcription-mediated amplification in patients with complete virologic response according to polymerase chain reaction-based assays.
Sarrazin C; Teuber G; Kokka R; Rabenau H; Zeuzem S
Hepatology; 2000 Oct; 32(4 Pt 1):818-23. PubMed ID: 11003628
[TBL] [Abstract][Full Text] [Related]
32. Impact of a sustained virological response on the long-term outcome of hepatitis C.
Alberti A
Liver Int; 2011 Jan; 31 Suppl 1():18-22. PubMed ID: 21205133
[TBL] [Abstract][Full Text] [Related]
33. Long-term monitoring of platelet count, as a non-invasive marker of hepatic fibrosis progression and/or regression in patients with chronic hepatitis C after interferon therapy.
Taniguchi H; Iwasaki Y; Fujiwara A; Sakaguchi K; Moriya A; Yu PC; Takaki A; Fujioka S; Shimomura H; Shiratori Y
J Gastroenterol Hepatol; 2006 Jan; 21(1 Pt 2):281-7. PubMed ID: 16460487
[TBL] [Abstract][Full Text] [Related]
34. Is serum uric acid a predictive factor of response to IFN-treatment in patients with chronic hepatitis C infection?
Pellicano R; Puglisi G; Ciancio A; Balzola F; Saracco G; Ciccone G; Baldi I; Abate ML; Smedile A; Rizzetto M
J Med Virol; 2008 Apr; 80(4):628-31. PubMed ID: 18297716
[TBL] [Abstract][Full Text] [Related]
35. Sequential serum hepatitis C viral RNA levels longitudinally assessed by branched DNA signal amplification.
Gordon SC; Dailey PJ; Silverman AL; Khan BA; Kodali VP; Wilber JC
Hepatology; 1998 Dec; 28(6):1702-6. PubMed ID: 9828238
[TBL] [Abstract][Full Text] [Related]
36. Clinical, virologic and pathologic significance of elevated serum gamma-glutamyl transpeptidase in patients with chronic hepatitis C.
Hwang SJ; Luo JC; Lai CR; Chu CW; Tsay SH; Lu CL; Wu JC; Chang FY; Lee SD
Zhonghua Yi Xue Za Zhi (Taipei); 2000 Jul; 63(7):527-35. PubMed ID: 10934805
[TBL] [Abstract][Full Text] [Related]
37. Transcription-mediated amplification is more sensitive than conventional PCR-based assays for detecting residual serum HCV RNA at end of treatment.
Comanor L; Anderson F; Ghany M; Perrillo R; Heathcote EJ; Sherlock C; Zitron I; Hendricks D; Gordon SC
Am J Gastroenterol; 2001 Oct; 96(10):2968-72. PubMed ID: 11693334
[TBL] [Abstract][Full Text] [Related]
38. Clinical outcome of chronic hepatitis C in patients treated with interferon: comparison between responders and non-responders.
Morisco F; Marmo R; Iasevoli P; Sessa G; Tuccillo C; Del Vecchio Blanco C; Caporaso N
Ital J Gastroenterol Hepatol; 1999; 31(6):454-8. PubMed ID: 10575561
[TBL] [Abstract][Full Text] [Related]
39. Association of lipid profiles with hepatitis C viral load in chronic hepatitis C patients with genotype 1 or 2 infection.
Hsu CS; Liu CH; Liu CJ; Wang CC; Chen CL; Lai MY; Chen PJ; Chen DS; Kao JH
Am J Gastroenterol; 2009 Mar; 104(3):598-604. PubMed ID: 19262519
[TBL] [Abstract][Full Text] [Related]
40. [Chronic hepatitis C].
Grammatikos G; Sarrazin C
Dtsch Med Wochenschr; 2010 Dec; 135(50):2525-34; quiz 2535-8. PubMed ID: 21140330
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
